The PROPHY-VAP Trial: Ceftriaxone to Prevent VAP in Patients with Acute Brain Injury
REBEL EM
FEBRUARY 29, 2024
1, 2 Its occurrence often portends worse outcomes in intubated patients, whose projected hospital course was already tenuous. PMID: 38262428 Clinical Question: Does antibiotic prophylaxis with a single dose of ceftriaxone reduce the incidence of early VAP in adults with severe brain injury who require mechanical ventilation?
Let's personalize your content